Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|October 12, 2023
Safety profile of inactivated COVID-19 in healthy adults aged ≥ 18 years: A passive surveillance in IndonesiaNastiti Kaswandani, Bernie Endyarni Medise, Elcha Leonard, et al.
Frontiers in Neurology|August 23, 2023
The efficacy and safety of first-line anti-seizure medications as substitution therapy for children with drug-resistant epilepsy: a randomized controlled trial protocolRoro Rukmi Windi Perdani, Wawaimuli Arozal, Irawan Mangunatmadja, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|February 8, 2024
Immunization Simulation Using Actual-Size Infant Manikins for Medical Students in Indonesia: A Quasi-Experimental StudyHartono Gunardi, Angga Wirahmadi, Bernie Endyarni Medise, et al.
Journal of Medical Internet Research|April 3, 2023
Evaluating the Efficacy of a Social Media-Based Intervention (Warna-Warni Waktu) to Improve Body Image Among Young Indonesian Women: Parallel Randomized Controlled TrialKirsty M Garbett, Sharon Haywood, Nadia Craddock, et al.
Frontiers in Pediatrics|May 1, 2024
Understanding the pubertal, psychosocial, and cognitive developmental trajectories of stunted and non-stunted adolescents: protocol of a multi-site Indonesian cohort studyBernie Endyarni Medise, Madarina Julia, Yoga Devaera, et al.
Healthcare (Basel, Switzerland)|January 11, 2024
Mental Health Awareness and Promotion during the First 1000 Days of Life: An Expert ConsensusHasto Wardoyo, Nila Djuwita Moeloek, Ray Wagiu Basrowi, et al.
Global Epidemiology|June 15, 2026
Safety profile following mRNA-1273 COVID-19 primary vaccination in healthy adults in IndonesiaBernie Endyarni Medise, Nastiti Kaswandani, Nina Dwi Putri, et al.
BMC Pediatrics|May 29, 2018
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months oldHartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, et al.
BMC Pediatrics|October 16, 2020
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary reportBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 1, 2020
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate VaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
Pageof 3